EP-1819: REQUITE: Validating predictive models and biomarkers of RT toxicity to reduce side-effects and improve QOL

MLA

Christopher J. Talbot, et al. “EP-1819: REQUITE: Validating Predictive Models and Biomarkers of RT Toxicity to Reduce Side-Effects and Improve QOL.” Radiotherapy and Oncology, vol. 111, Jan. 2014, p. S296. EBSCOhost, https://doi.org/10.1016/s0167-8140(15)31937-x.

APA

Christopher J. Talbot, S. Gutiérrez Enríquez, Ana Vega, Jenny Chang-Claude, Liv Veldeman, L. Lozza, D. Azria, Dirk De Ruysscher, Catharine M L West, & Alison M. Dunning. (2014). EP-1819: REQUITE: Validating predictive models and biomarkers of RT toxicity to reduce side-effects and improve QOL. Radiotherapy and Oncology, 111, S296. https://doi.org/10.1016/s0167-8140(15)31937-x

Chicago

Christopher J. Talbot, S. Gutiérrez Enríquez, Ana Vega, Jenny Chang-Claude, Liv Veldeman, L. Lozza, D. Azria, Dirk De Ruysscher, Catharine M L West, and Alison M. Dunning. 2014. “EP-1819: REQUITE: Validating Predictive Models and Biomarkers of RT Toxicity to Reduce Side-Effects and Improve QOL.” Radiotherapy and Oncology 111 (January): S296. doi:10.1016/s0167-8140(15)31937-x.